Michael Rickoff
Gastroenterology · Greenville, SCNPI 1851373724
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $11,375 of the $15,503 with a category attached, or 73.4%. 24 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 56.5% of the total. Reporting peaked in 2021 at $5,471 and has fallen 99.7% since, to $14 in 2024.
Across 175 payments — averaging $88.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$9K
- QOL Medical, LLC$4K
- AbbVie$1K
- Bristol Myers Squibb$655
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$269
- Merck$244
- plus $821 from 18 others
What the payments were for
- Consulting fees$1,2008%
- Speaking & faculty fees$11,37573%
- Food & beverage$2,90519%
- Education$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 6 | $8,752 |
| QOL Medical, LLC | 12 | $3,628 |
| AbbVie | 74 | $1,135 |
| Bristol Myers Squibb | 5 | $655 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $269 |
| Merck | 9 | $244 |
| Pfizer | 8 | $121 |
| Johnson & Johnson | 7 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $101 |
| Ironwood Pharmaceuticals, Inc | 5 | $73 |
| Ferring Pharmaceuticals Inc. | 4 | $67 |
| Gilead | 3 | $54 |
| Intercept Pharmaceuticals, Inc. | 3 | $47 |
| Nestle Healthcare Nutrition Inc. | 3 | $46 |
| Alnylam Pharmaceuticals Inc. | 2 | $42 |
| Sanofi | 2 | $33 |
| Daiichi Sankyo Inc. | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $17 |
| Ardelyx, Inc. | 1 | $16 |
| Medtronic | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
| UCB, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,503 in reported general payments places this provider in the 85th percentile of 259 gastroenterology providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SucraidSacrosidase | 11 | $152,768 |
| ZenpepLipase/Protease/Amylase | 24 | $97,083 |
| CreonLipase/Protease/Amylase | 13 | $57,768 |
| NexiumEsomeprazole Magnesium | 13 | $9,497 |
| Rabeprazole Sodium | 28 | $1,595 |
| Colestipol Hcl | 13 | $1,183 |
| Esomeprazole Magnesium | 19 | $520 |
| Omeprazole | 55 | $514 |
| Pantoprazole Sodium | 47 | $504 |
| Sucralfate | 12 | $456 |
| Famotidine | 50 | $444 |
| Dicyclomine Hcl | 12 | $304 |
| Ondansetron OdtOndansetron | 12 | $195 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| QOL Medical, LLCSucraid | $3,628 | $152,76811 claims |
| AbbVieCreon | $1,135 | $57,76813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 259 gastroenterology providers in South Carolina.
Other gastroenterology in Greenville
- Andre EaddyGreenville$212K
- Veeral OzaGreenville$199K
- Christina BauerGreenville$179K
- Joseph LebelGreenville$22K
- Joseph BaberGreenville$11K
- John EdmisonGreenville$10K
- Madhusudhan SunkavalliGreenville$9K
- Erin ForsterCharleston$788K
- Mark DeleggeCharleston$568K
- Nathan ShoresCharleston$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.